Dravet Syndrome

Also known as: Severe myoclonic epilepsy of infancy / Epilepsy, Myoclonic, Infantile, Severe / Severe myoclonic epilepsy in infancy (disorder)

DrugDrug NameDrug Description
DB00574FenfluramineFenfluramine is a phenethylamine that is structurally similar to serotonin. Due to its ability to increase extracellular serotonin levels, modulate serotonergic and other neurologic receptors, and control neurotransmission, it is effective in treating pharmacoresistant seizures.
DB09118StiripentolAn anticonvulsant agent used with clobazam and valproate as an adjunct to treat refractory generalized tonic-clonic seizures in Dravet syndrome.
DrugDrug NamePhaseStatusCount
DB15932Clemizole1Completed1
DB09061Cannabidiol1 / 2Completed1
DB09061Cannabidiol1 / 2Terminated1
DB00574Fenfluramine1 / 2Completed1
DB09061Cannabidiol2Completed1
DB15932Clemizole2Recruiting1
DB11062Octisalate2Recruiting1
DB09535Octocrylene2Recruiting1
DB00661Verapamil2Completed1
DB09321Zinc oxide2Recruiting1
DB09061Cannabidiol3Completed3
DB09061Cannabidiol3Recruiting1
DB09061Cannabidiol3Withdrawn1
DB00349Clobazam3Terminated1
DB00349Clobazam3Withdrawn1
DB00574Fenfluramine3Active Not Recruiting2
DB00574Fenfluramine3Completed1
DB00574Fenfluramine3Enrolling by Invitation2
DB00574Fenfluramine3Recruiting1
DB00574FenfluramineNot AvailableApproved for Marketing1
DB00574FenfluramineNot AvailableAvailable1
DB09118StiripentolNot AvailableApproved for Marketing1
DB09118StiripentolNot AvailableNo Longer Available3